OncoMatch/Clinical Trials/NCT07673016
Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer
Is NCT07673016 recruiting? Yes, currently enrolling (Sep 2026).
RecruitingConvergent Genomics, Inc.NCT07673016Data as of Sep 2026Location: United States · Puerto Rico
Check if I qualifyExtracted eligibility criteria
Cancer type
Urothelial Carcinoma
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- Urology San Diego · Oceanside, California
- Genesis Research, LLC · San Diego, California
- Urology Associates of Silicon Valley · San Jose, California
- UroPartners, LLC · Chicago, Illinois
- UroPartners, LLC · Grayslake, Illinois
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT07673016 currently recruiting?
Yes, this trial is currently recruiting patients.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages